Topic:

sarepta

Sarepta shares drop as report says FDA almost rejected under-review gene therapy

by Reuters April 13, 2023

(Reuters) – Sarepta Therapeutics Inc’s shares fell as much as 19.4% premarket on Thursday as Stat News reported that the U.S. Food and Drug Administration’s staff were inclined to reject …
Sarepta slides as FDA about-turn on panel clouds gene therapy approval path

by Reuters March 17, 2023

By Aditya Samal (Reuters) -Shares of Sarepta Therapeutics Inc slumped as much as 21% on Friday on uncertainty over its gene therapy for Duchenne muscular dystrophy after the U.S. health …

Sarepta shares drop as report says FDA almost rejected under-review gene therapy